Ovarian cancer study proves drug dela...

Ovarian cancer study proves drug delays disease progression, may improve survival

There are 1 comment on the EurekAlert! story from Dec 28, 2011, titled Ovarian cancer study proves drug delays disease progression, may improve survival. In it, EurekAlert! reports that:

Treating ovarian cancer with the drug bevacizumab delays the disease and may also improve survival, show the results of an international clinical trial co-led by Drs.

Join the discussion below, or Read more at EurekAlert!.

Since: Dec 05

Reading, PA

#1 Dec 30, 2011
With Low-dose Chemotherapy - You Wouldn't Need Avastin

Many chemotherapy drugs, in addition to killing tumor cells, also fight angiogenesis. However, the anti-angiogenic effects of dose-dense therapy may be masked and marginalized by the way it is usually administered. The main targets of high-dose chemotherapy are presumed to be proliferating tumor cells. The main targets of low-dose chemotherapy are the endothelial cells of the growing vasculature of a tumor. In other words, chemotherapeutics are used as anti-angiogenic agents.

The process of angiogenesis is controlled by two distinct types of proteins, referred to as "angiogenic growth factors" and "angiogenesis inhibitors." Medical researchers have identified 19 angiogenic growth factors in the human body and 31 angiogenesis inhibitors. In a healthy body, a perfect balance of factors that promote and prevent angiogenesis is maintained. After cells become cancerous, the regulation of this balance is disturbed, stimulating the production of new blood vessels.

Targeted therapies, such as Avastin, were originally designed with the goal of replacing chemotherapy, to reduce the serious morbidities associated with standard high-dose chemotherapy. Although targeted therapies may be somewhat less toxic, most of them have been found to have very modest efficacy, at least when used as single agents in treating patients with advanced disease. They have therefore mainly been used in combination with standard chemotherapy or radiation protocols.

It is becoming more apparent to administer drugs to patients with certain types of cancer on a weekly schedule. The advantage of low-dose chemotherapy is the possibility of combining it with anti-angiogenic drugs as well as other types of targeted therapies, such as those that target specific signal-transduction molecules or with antitumor vaccines.

Blood vessel cells are less likely than tumor cells to become resistant to chemotherapy, so if cancer cells become drug resistant, these medicines should still be able to shrink tumors by destroying their blood supply. When administering both anti-tumor and anti-angiogenesis drugs, the endothelial cells (involved iin angiogenesis) are the first in the tumor to undergo cell death (apoptosis).

Adding Avastin, which only goes after VEGF-sensitive cancer cells, you need to go after other pro-angiogenic factors which can substitute for VEGF: FGF, PDGF, ephrin A1, angioprotein 1, IL-8, etc. And with Taxol promoting an increase of IL-8, how effective is it with Avastin? With the low-dose protocol having an anti-angiogenic effect, you really wouldn't need to add a drug like Avastin into the mix.

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Oncology Discussions

Title Updated Last By Comments
News Biden Hosting Cancer Summit to Try to Accelerat... Jun 29 Unsolicited Advice 2
News Biden hosting cancer summit to try to accelerat... Jun '16 Le Jimbo 1
News Racially biased cancer doctors spend less time ... Jun '16 Summer Friend 6
Thoughts on new CMS rules for billing on ambula... Jun '16 Novice 1
News Long-term outcomes in radically treated synchro... Jun '16 why use BIG words 1
News Screening for breast and cervical cancer is a p... May '16 Three Days 5K 1
News Not just pets: Dogs, cats may show way to bette... May '16 Dumb Animals 2
More from around the web